Xtl Biopharmaceuticals (XTLB) Cash from Investing Activities (2009 - 2024)
Xtl Biopharmaceuticals (XTLB) posted quarterly Cash from Investing Activities of -$237000.0 for Q4 2024, down 23800.0% on a QoQ basis from $1000.0 in Q2 2016.
Xtl Biopharmaceuticals (XTLB) Cash from Investing Activities (2009 - 2024) Analysis & Trends
Xtl Biopharmaceuticals (XTLB) has reported Cash from Investing Activities for 9 consecutive years, with -$237000.0 the latest figure, recorded in Q4 2024.
- Quarterly Cash from Investing Activities changed N/A year-over-year to -$237000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$237000.0 (changed N/A YoY) and the FY2025 annual result came in at $522000.0, up 161.85% from the prior year.
- Cash from Investing Activities fell to -$237000.0 in Q4 2024 per XTLB's latest filing, from $1000.0 in the prior quarter.
- Over the last five years, Cash from Investing Activities for XTLB reached as high as -$237000.0 in Q4 2024 and fell as low as -$237000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | - |
| 4 | BeOne Medicines | 470.64 Bn | 465.84 Bn | 1.35 Bn | -45.51 Mn |
| 5 | Vertex Pharmaceuticals | 122.91 Bn | 115.67 Bn | 2.59 Bn | -431.90 Mn |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn | -428.90 Mn |
| 7 | Belite Bio | 62.77 Bn | 62.77 Bn | - | - |
| 8 | Argenx Se | 56.21 Bn | 51.02 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.60 Bn | 37.60 Bn | - | 172.62 Mn |
| 10 | Xtl Biopharmaceuticals | 2.51 Bn | 2.51 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -237,000.00 |
| Dec 31, 2024 | -237,000.00 |
| Jun 30, 2016 | 1,000.00 |
| Jun 30, 2016 | 1,000.00 |
| Dec 31, 2015 | -54,000.00 |
| Dec 31, 2015 | -54,000.00 |
| Sep 30, 2015 | -63,000.00 |
| Sep 30, 2015 | -63,000.00 |
| Jun 30, 2015 | -14,000.00 |
| Jun 30, 2015 | -14,000.00 |
| Dec 31, 2014 | 516,000.00 |
| Dec 31, 2014 | 516,000.00 |
| Sep 30, 2014 | 116,000.00 |
| Sep 30, 2014 | 116,000.00 |
| Jun 30, 2014 | 538,000.00 |
| Jun 30, 2014 | 538,000.00 |
| Mar 31, 2014 | 279,000.00 |
| Mar 31, 2014 | 279,000.00 |
| Dec 31, 2013 | -945,000.00 |
| Dec 31, 2013 | -945,000.00 |